Kupchik M, Spivak B, Mester R, Reznik I, Gonen N, Weizman A, Kotler M
Ness Ziona Mental Health Center, Israel.
Clin Neuropharmacol. 2000 Jan-Feb;23(1):14-6. doi: 10.1097/00002826-200001000-00003.
We reviewed 36 reported psychiatric patients who were treated with a combination of electroconvulsive therapy (ECT) and clozapine. The indication of the ECT-clozapine treatment was resistance to classical antipsychotic agents, clozapine, or ECT alone. Sixty-seven percent of the patients benefited from the combined treatment. In most of the patients, the combined treatment was safe and well tolerated. Adverse reactions occurred in 16.6% of the patients and included prolonged ECT-induced seizures (one case), supraventricular (one case) and sinus tachycardia, and blood pressure elevation. It seems that combined ECT-clozapine treatment is effective and safe. This strategy may be a therapeutic option in treatment-resistant patients.
我们回顾了36例接受电休克治疗(ECT)与氯氮平联合治疗的精神病患者。ECT-氯氮平联合治疗的适应证为对传统抗精神病药物、氯氮平或单独ECT治疗耐药。67%的患者从联合治疗中获益。大多数患者对联合治疗耐受良好且安全。16.6%的患者出现不良反应,包括ECT诱发的癫痫发作延长(1例)、室上性(1例)和窦性心动过速以及血压升高。ECT-氯氮平联合治疗似乎有效且安全。该策略可能是治疗耐药患者的一种治疗选择。